Roepke, Stefan
Schoofs, Nikola
Priebe, Kathlen
Wülfing, Felix
Schmahl, Christian
Röhle, Robert
Zähringer, Jenny
Lotter, Tobias
Otte, Christian
Koglin, Stefanie
Funding for this research was provided by:
Charité - Universitätsmedizin Berlin
Article History
Received: 24 April 2023
Accepted: 25 April 2023
First Online: 5 May 2023
Declarations
:
: The study has been approved by a German ethics committee—Ethik-Kommission des Landes Berlin (Reference: 19/0384 – IV E 11) on January 22, 2020 (see InternalRef removed for approval). The study was performed in accordance with relevant guidelines and regulations.
: Not applicable.
: S.R. reports personal fees from Janssen, Otsuka, Bionorica SE (prior to signature of study contract), Boehringer Ingelheim, and Stillachhaus outside the submitted work and reports grants from the German Research Foundation (DFG), German Ministry of Education and Research (BMBF), and Innovationsfond. N.S., K.P., F.W., R.R., J.Z., T.L., and S.K. report no COI. C.S. reports personal fees from Boehringer Ingelheim outside the submitted work. C.O. reports honoraria for lectures and/or scientific advice from Janssen, Limes Klinikgruppe, Lundbeck, Neuraxpharm, and Peak Profiling, and research funding from the Deutsche Forschungsgemeinschaft (OT 209/7–3; 14–1, 19–1, EXC 2049), the European Commission (IMI2 859366), the German Federal Ministry of Education and Research (KS2017-067), and the Berlin Institute of Health (B3010350).